In breast cancer, PD-L1 helps maintain a stemness phenotype in MICs in vitro and in a mouse xenograft model via PI3K/AKT signaling that leads to phosphorylation of OCT4 and subsequent regulation of OCT4 and NANOG expression 42. This evidence concerns the gene NANOG and breast cancer.